National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$45.00
add to cart

Rights & Permissions

topleft topright

The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary (2003)
Board on Global Health (BGH)
Institute of Medicine (IOM)

Citation Manager

. "4. The Economics of Resistance." The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary. Washington, DC: The National Academies Press, 2003.

Please select a format:

BibTeX EndNote RefMan


Page
129
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Smith RD, Coast J, Millar MR. 1996. Over-the-counter antimicrobials: the hidden costs of resistance. Journal of Antimicrobial Chemotherapy37:1031–1032.

Smith RD, Coast J, Millar MR, Wilton P, Karcher A-M. 2001. Interventions Against Anti-Microbial Resistance: a Review of the Literature and Exploration of Modelling Cost- Effectiveness. Report to: Global Forum for Health Research.Geneva: World Health Organization.

Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. 1998. The Path of Least Resistance. [Online]. Available: http://www.doh.gov.uk/smac1.htm.

Tietenberg T. 1990. Economic instruments for environmental regulation. Oxford Review of Economic Policy6:17–33.

Tomasz A. 1994. Multiple-antibiotic resistant pathogenic bacteria. A report on the Rockefeller University workshop. New England Journal of Medicine330:1247–1251.

Turner R, Pearce D, Bateman I. 1994. Environmental Economics. An Elementary Introduc tion.London: Harvester Wheatsheaf.


Weitzman M. 1974. Prices versus quantities. Review of Economic Studies41:477–491.

WHO (World Health Organization). 2001. Global Strategy for the Containment of Antimi crobial Resistance.WHO/CDS/CSR/DRS/2001.2. Geneva: WHO.

Wilton P, Smith RD, Coast J, Millar M. 2002. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. Journal of Health Services Research and Policy7:111–117.

Wilton P, Smith RD, Coast J, Millar M, Karcher A. 2001. Directly observed therapy for multi-drug resistant tuberculosis: an economic evaluation in the United States of America and South Africa. The International Journal of Tuberculosis and Lung Disease5:1137– 1142.

Winebrake J, Farrell A, Bernstein M. 1995. The Clean Air Act’s sulfur dioxide emissions market: estimating the costs of regulatory and legislative intervention. Resource and Energy Economics17:239–260.

World Bank. 2001. World Development Report 2000/01. New York: Oxford University Press.

Page
129